Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | EBP | Q15125 | 1/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | ACACB | O00763 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | REN | P00797 | 1/20 | 0.41 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8323180 | 1.00 | TSHR (0.55) | TSHRTP53EBPSIGMAR1RECQL | |
| SCHEMBL8967452 | 1.00 | TSHR (0.55) | TSHRTP53EBPSIGMAR1RECQL | |
| SCHEMBL6989159 | 0.91 | TP53 (0.50) | TSHRTP53EBPSIGMAR1RECQL | |
| SCHEMBL17706564 | 0.86 | TP53 (0.46) | TSHRTP53EBPSIGMAR1RECQL | |
| SCHEMBL11459690 | 0.83 | ADORA3 (0.52) | TSHRTP53EBPSIGMAR1ACACB | |
| SCHEMBL10454154 | 0.82 | TP53 (0.38) | TSHRTP53EBPSIGMAR1RECQL | |
| SCHEMBL6381994 | 0.82 | TSHR (0.52) | TSHRTP53EBPSIGMAR1RECQL | |
| SCHEMBL29160521 | 0.81 | TP53 (0.68) | TSHRTP53EBPSIGMAR1RECQL | |
| SCHEMBL6044363 | 0.81 | TP53 (0.51) | TSHRTP53EBPSIGMAR1RECQL | |
| SCHEMBL6044360 | 0.81 | TP53 (0.51) | TSHRTP53EBPSIGMAR1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| CN-102596870-B | Method for producing m-substituted phenylalkanols by means of isomerization | BASF SE | 2014-11-05 | — | — | CN | claimed |
| EP-2490993-B1 | METHOD FOR PRODUCING M-SUBSTITUTED PHENYLALKANOLS BY MEANS OF ISOMERIZATION | BASF SE (DE) | 2014-06-11 | — | — | EP | claimed |
| CN-103304388-A | Asymmetric synthesis method of (R)- or (S)-Lily aldehyde | FOURTH MILITARY MEDICAL UNIV | 2013-09-18 | — | — | CN | claimed |
| EP-2568954-A2 | FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | Segetis, Inc. (US) | 2013-03-20 | — | — | EP | claimed |
| EP-2490993-A2 | METHOD FOR PRODUCING M-SUBSTITUTED PHENYLALKANOLS BY MEANS OF ISOMERIZATION | BASF SE (DE) | 2012-08-29 | — | — | EP | claimed |
| US-20120209031-A1 | METHOD FOR PRODUCING M-SUBSTITUTED PHENYLALKANOLS BY MEANS OF ISOMERIZATION | BASF SE (DE) | 2012-08-16 | — | — | US | claimed |
| CN-102596870-A | Method for producing m-substituted phenylalkanols by means of isomerization | BASF SE | 2012-07-18 | — | — | CN | claimed |
| EP-2072083-B1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | SYMRISE AG (DE) | 2012-02-15 | — | — | EP | claimed |
| EP-0799299-A4 | SILICONE COMPOSITIONS | PROCTER & GAMBLE (US) | 1999-08-18 | — | — | EP | claimed |
| EP-0794763-A4 | SILICONE COMPOSITIONS | PROCTER & GAMBLE (US) | 1999-06-09 | — | — | EP | claimed |
| EP-0799299-A1 | SILICONE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-10-08 | — | — | EP | claimed |
| EP-0799300-A1 | SILICONE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-10-08 | — | — | EP | claimed |
| EP-0794763-A1 | SILICONE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-17 | — | — | EP | claimed |
| EP-0792110-A1 | SILICONE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1996019561-A1 | SILICONE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-06-27 | — | — | WO | claimed |
| WO-1996019194-A1 | SILICONE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-06-27 | — | — | WO | claimed |
| WO-1996019119-A1 | SILICONE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-06-27 | — | — | WO | claimed |
| WO-1996019562-A1 | SILICONE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-06-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120209031-A1 | METHOD FOR PRODUCING M-SUBSTITUTED PHENYLALKANOLS BY MEANS OF ISOMERIZATION | CRAT, CYP2E1, C9 | TSHR 3887/4885TP53 2406/4885EBP 193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.